Brief: Tack Fiori updates on acquisition of 30% equity interest in Manrui Biotech

King International Investment

01/08/2016 14:12

Aug 1 (Reuters) - Tack Fiori International Group Ltd  0928.HK : 
 * Discloseable transaction in relation to the acquisition of 30% equity 
   interest in Manrui Biotech  
 * The aggregate consideration payable by the group under the agreement is RMB60 
   million 
 * Cash portion of the consideration will be funded by the group's internal 
   resources 
 
* Source text for Eikon  ID:nHKS3qKyCZ  
 
* ((For more news, please click here  0928.HK )) ((Bengaluru Newsroom; +91 80 
6749 1130))